Literature DB >> 25546775

Fc-dependent mechanisms of action: roles of FcγR and FcRn.

T Kuijpers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546775      PMCID： PMC4285504          DOI： 10.1111/cei.12524

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.

Authors:  Manuel D Carcao; Victor S Blanchette; Cindy D Wakefield; Derick Stephens; Janet Ellis; Kimberly Matheson; Gregory A Denomme
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

2.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors:  Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal:  Nat Genet       Date:  2011-11-13       Impact factor: 38.330

Review 3.  Fcgamma receptors as regulators of immune responses.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 4.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

5.  Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.

Authors:  Sietse Q Nagelkerke; Gillian Dekkers; Iwan Kustiawan; Fleur S van de Bovenkamp; Judy Geissler; Rosina Plomp; Manfred Wuhrer; Gestur Vidarsson; Theo Rispens; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2014-10-28       Impact factor: 22.113

6.  Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

Authors:  Robert M Anthony; Toshihiko Kobayashi; Fredrik Wermeling; Jeffrey V Ravetch
Journal:  Nature       Date:  2011-06-19       Impact factor: 49.962

7.  Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles.

Authors:  Joris van der Heijden; Willemijn B Breunis; Judy Geissler; Martin de Boer; Timo K van den Berg; Taco W Kuijpers
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

8.  Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura.

Authors:  Willemijn B Breunis; Edwin van Mirre; Marrie Bruin; Judy Geissler; Martin de Boer; Marjolein Peters; Dirk Roos; Masja de Haas; Harry R Koene; Taco W Kuijpers
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 9.  Immune thrombocytopenia in adults: an update.

Authors:  Swapna Thota; Gaurav Kistangari; Hamed Daw; Timothy Spiro
Journal:  Cleve Clin J Med       Date:  2012-09       Impact factor: 2.321

Review 10.  The antiinflammatory activity of IgG: the intravenous IgG paradox.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.